Diagnostic performance of rK28- and rK39-based rapid diagnostic tests for Visceral Leishmaniasis in Kenya: Implications for the national diagnostic algorithm

Background Visceral Leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania infantum and L. donovani and transmitted by an infectious bite of a female phlebotomine sandfly. The disease disproportionately affects impoverished and underserved populations, where inadequate access to healthcare. In Kenya, 11 out of the 47 counties are endemic for VL, a fatal disease if untreated. Parasitological methods remain the gold standard for diagnosing VL, however they are invasive and require specialised training and equipment. Serological tests such as Rapid Diagnostic Tests (RDTs) are widely used for screening but can still report positive results way after treatment due to persistence of anti-VL antibodies. It is recommended that VL diagnosis follows an algorithmic approach. This study evaluated diagnostic performance of rK28 and rK39 RDTs (Kala-azar Detect and IT Leish) in various algorithmic combinations against a composite reference standard. Methodology We evaluated rK28 and Kala-azar Detect along with rK39 IT-Leish as index tests, and Direct Agglutination Test (DAT) as the reference test. Participants were recruited from seven health facilities in Marsabit and Turkana counties. Blood samples were collected together with patient demographic data. Treatment followed the national algorithm and health facility routine procedures. Diagnostic test performance was assessed individually, in parallel, and sequential algorithmic combinations. Specificity, sensitivity, balanced accuracy, negative and positive predictive values were statistically estimated. Results A total of 398 participants were recruited, with most reported clinical symptoms being fever and splenomegaly. Individually, the rK28 kit demonstrated 96% sensitivity, 86% specificity, and 91.2% balanced accuracy (BA). The rK39 IT-Leish had 87% sensitivity, specificity 93%, and BA of 90.4%, while Kala-azar Detect had 67% sensitivity, 91% specificity and 79% BA. IT Leish to rK28 algorithm based on negatives had highest BA (90%), with 92% sensitivity and 88% specificity, while rK28 to Kala-azar detect algorithm based on positives showed the lowest BA (80%) with 65% sensitivity and 94.1% specificity. Discussion The rK28 RDT demonstrated high sensitivity (96–98%) and moderate specificity (72–86%), findings broadly consistent with reports elsewhere. In contrast, the rK39-based tests showed higher specificity (91–93%) but lower sensitivity (67–87%), limiting their effectiveness in elimination programs. Parallel testing algorithms combining rK28 and rK39 RDTs improved sensitivity up to 97.7%, whereas sequential approaches increased specificity at the expense of sensitivity when compared to rK28 alone. These approaches were more balanced as compared to sequential which increased overall specificity and reduced sensitivity. This flexibility in combinations provides more options for elimination programs. The performance of rK28 gives it an advantage over rK39 kits, especially with IT Leish facing stockouts. While the study faced limitations including lack of PCR data leading to reliance on DAT as the reference standard, and underpowered secondary analyses, the findings provide strong preliminary evidence guiding national algorithm, supply chain, and policy decisions that may accelerate VL elimination. Conclusion The findings demonstrate that diagnostic algorithms incorporating rK28 provide robust performance for VL diagnosis. They support consideration of rK28 diagnostic kit for VL diagnostic algorithms enhancing case detection for control and elimination efforts in Eastern Africa

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.13.26368071
Primary Topic
Research on Leishmaniasis Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Diagnostic performance of rK28- and rK39-based rapid diagnostic tests for Visceral Leishmaniasis in Kenya: Implications for the national diagnostic algorithm

Kelvin Thiong’o, Joseph Mathu Ndung’u, Robert Ofwete, Bernard Osero et al.
medRxiv
Research on Leishmaniasis Studies
preprint

Diagnostic performance of rK28- and rK39-based rapid diagnostic tests for Visceral Leishmaniasis in Kenya: Implications for the national diagnostic algorithm

Kelvin Thiong’o, Joseph Mathu Ndung’u, Robert Ofwete, Bernard Osero, Damaris Matoke-Muhia, Bryson Brian Kimemia, Dawn Maranga, Mercy Tuluso, Luna Kamau
preprint en

Abstract

Background Visceral Leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania infantum and L. donovani and transmitted by an infectious bite of a female phlebotomine sandfly. The disease disproportionately affects impoverished and underserved populations, where inadequate access to healthcare. In Kenya, 11 out of the 47 counties are endemic for VL, a fatal disease if untreated. Parasitological methods remain the gold standard for diagnosing VL, however they are invasive and require specialised training and equipment. Serological tests such as Rapid Diagnostic Tests (RDTs) are widely used for screening but can still report positive results way after treatment due to persistence of anti-VL antibodies. It is recommended that VL diagnosis follows an algorithmic approach. This study evaluated diagnostic performance of rK28 and rK39 RDTs (Kala-azar Detect and IT Leish) in various algorithmic combinations against a composite reference standard. Methodology We evaluated rK28 and Kala-azar Detect along with rK39 IT-Leish as index tests, and Direct Agglutination Test (DAT) as the reference test. Participants were recruited from seven health facilities in Marsabit and Turkana counties. Blood samples were collected together with patient demographic data. Treatment followed the national algorithm and health facility routine procedures. Diagnostic test performance was assessed individually, in parallel, and sequential algorithmic combinations. Specificity, sensitivity, balanced accuracy, negative and positive predictive values were statistically estimated. Results A total of 398 participants were recruited, with most reported clinical symptoms being fever and splenomegaly. Individually, the rK28 kit demonstrated 96% sensitivity, 86% specificity, and 91.2% balanced accuracy (BA). The rK39 IT-Leish had 87% sensitivity, specificity 93%, and BA of 90.4%, while Kala-azar Detect had 67% sensitivity, 91% specificity and 79% BA. IT Leish to rK28 algorithm based on negatives had highest BA (90%), with 92% sensitivity and 88% specificity, while rK28 to Kala-azar detect algorithm based on positives showed the lowest BA (80%) with 65% sensitivity and 94.1% specificity. Discussion The rK28 RDT demonstrated high sensitivity (96–98%) and moderate specificity (72–86%), findings broadly consistent with reports elsewhere. In contrast, the rK39-based tests showed higher specificity (91–93%) but lower sensitivity (67–87%), limiting their effectiveness in elimination programs. Parallel testing algorithms combining rK28 and rK39 RDTs improved sensitivity up to 97.7%, whereas sequential approaches increased specificity at the expense of sensitivity when compared to rK28 alone. These approaches were more balanced as compared to sequential which increased overall specificity and reduced sensitivity. This flexibility in combinations provides more options for elimination programs. The performance of rK28 gives it an advantage over rK39 kits, especially with IT Leish facing stockouts. While the study faced limitations including lack of PCR data leading to reliance on DAT as the reference standard, and underpowered secondary analyses, the findings provide strong preliminary evidence guiding national algorithm, supply chain, and policy decisions that may accelerate VL elimination. Conclusion The findings demonstrate that diagnostic algorithms incorporating rK28 provide robust performance for VL diagnosis. They support consideration of rK28 diagnostic kit for VL diagnostic algorithms enhancing case detection for control and elimination efforts in Eastern Africa

medRxiv
FIND (CH), Kenya Medical Research Institute (KE), Amref Health Africa (KE), Amref Health Africa (US), Amref Health Africa (TZ)
Research on Leishmaniasis Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon